Biomarker and Companion Diagnostics Annual 2 Day Conference – London, United Kingdom (March 7-8th, 2024)

DUBLIN, Jan. 3, 2024 /PRNewswire/ — The “5th Annual Biomarker and Companion Diagnostics Conference” has been added to  ResearchAndMarkets.com’s offering.

Leveraging Next-Gen Technologies Beyond Conventional Biomarker Drug Discovery

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

20+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Challenges in NGS-based CDx and the Importance of imaging biomarkers for precision medicine.Opportunity to develop long-lasting business relationships and networking opportunities with senior peers. Get the Opportunity to get your queries handled by Biomarker experts in a one-on-one session.Facilitated networking sessions to ensure quality interactions along with Case studies from experts who have successfully created and developed a biomarker

The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th – 8th March 2024 in London, UK would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area.

The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

Key Highlights:

Clinical biomarker identification and qualificationBiomarkers and personalized medicineAssay development and validationNGS and novel technologies in biomarker discoveryCommercialization of biomarkers in therapeutic and CDx applications

Speakers

Debora Souza Da Costa, Biosample Operations Specialist, RocheStephanie Traub, Associate Director, Translational Biomarkers & Bioanalysis, UCBRon Wolbert, Associate Director, Bioanalytical Scientific Manager, Translational Biomarkers & Bioanalysis, UCBPatrick Brossard, Director, Clinical Pharmacology, SOBI – Swedish Orphan Biovitrum ABSmiths Lueong, Head, Early Detection and Biomarkers, The Cameroon Consortium for Translational Cancer ResearchChristian Garde, Scientific Director, Bioinformatics, Evaxion Biotech A/SNathalie Steinhoff, Scientist, Cancer Immunotherapy, Numab Therapeutics AGShidong Jia, Founder, CEO, PredicineLiying Yan, President, Scientist, EpigenDxRobert Watson, Clinical Lecturer, University of OxfordRadha Krishnan, Executive Director and Clinical Pathology Lead, MerckJelmar Quist, Cancer Bioinformatician, King’s College LondonJessica Fowler, Market Development Executive, RocheAparna Duggirala, Lecturer, Clinical Genetics, University of DerbyChristopher Peters, Clinical Senior Lecturer, Imperial College London

For more information about this conference visit https://www.researchandmarkets.com/r/j85161

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/biomarker-and-companion-diagnostics-annual-2-day-conference—london-united-kingdom-march-7-8th-2024-302025425.html

SOURCE Research and Markets